Metal Intoxication: General Aspects and Chelating Agents
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Inorganic Chemistry".
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 11202
Special Issue Editors
Interests: coordination chemistry; spectroscopy; NMR spectroscopy; transition metals; toxic metals; neurodegeneration; metal complexes; peptides; amino acids; proteins; metal interaction; chelation therapy; chelating agents
Special Issues, Collections and Topics in MDPI journals
2. Institute of Chemical Engineering Sciences (ICE-HT), Foundation for Research and Technology, Hellas (FORTH), Patras, Greece
Interests: biochemistry; structural biology; NMR spectroscopy; transition metals; biotechnology; proteins; metal interaction; Wilson’s disease; coordination chemistry; bioinformatic
Special Issue Information
Dear Colleagues,
Several metals, such as sodium, potassium, magnesium, calcium, iron, manganese, cobalt, copper, zinc, and molybdenum, are essential for human health. They are indispensable elements for life, playing important roles in a wide variety of biological processes. Essential transition metals, like Fe, Mn, Cu, and Zn, participate in controlling various metabolic and signaling pathways. The human body needs appropriate amounts and their concentration has to be finely regulated, as any imbalance in their homeostasis can induce abnormalities.
Additionally, humans are also exposed to non-essential and toxic metals. Large environmental amounts of such chemicals come from both natural and anthropogenic sources, with the latter being predominant because of extensive metal mining and smelting, several industrial activities, incinerators, and the combustion of fossil fuel.
The dissipation of toxic metals, such as lead, mercury, arsenic, cadmium, aluminum, uranium, and tungsten contaminate water, air, soil, and food, causing a series of chronic and acute syndromes.
The characteristic coordination ability, dimension, and chemical properties of such metals make them, in particular circumstances, able to interact with protein sites other than those that are eventually tailored to them, by displacing other essential metals from their natural binding sites, leading to cell malfunctions and toxicity. Some of them (essential and not) possess redox properties and are a key inducer of reactive oxygen species, leading to oxidative stress and several cellular damage. If the doses of exposure exceed the capacity of the detoxification and homeostatic control, a sequence of cascade key events will occur at progressively higher levels of organization—from a cellular level (altered cell physiology, cycle and growth, cytotoxicity, genotoxicity, inflammation, altered mitochondria, and chloroplast function) to organ level (altered metabolism, altered organ physiology, altered nutrient dynamics, altered growth, and maintenance), until the whole organism responses (cancer, neurodegenerative disorders, organ failure, etc.). Clinical experience has demonstrated that acute and chronic metal intoxications can be treated efficiently using chelation therapy.
This clinical intervention involves the administration of chelating agents—molecules rationally designed to have a relatively higher affinity and selectivity for specific toxic metal ions, able to remove specific toxic metals from the body and maintain a safe and proper concentration at physiological levels for essential metals. They must form chemically inert and non-toxic metal complexes, and should not disturb the homeostasis of the essential biological metal ions. Moreover, chelating agents should enter the cell membrane to remove intracellular toxic metals, and should be rapidly and easily excreted from the body. An effective and safe chelating agent specific for each toxic metal ion, without side effects, is a challenging target. In addition, most available chelators do not cross the blood–brain barrier; consequently, they have a limited ability to remove metals from the brain tissue. The actual research is focused on evaluating the available chelating agents, improving their performances, and the development of new chelators and applications for clinical treatments.
This Special ssue aims to exploit heavy metal toxicity in humans, the chelation approach for their removal from the body, and to present the reader with the latest progress in the development of chelating strategies to treat chronic and acute metal intoxication. Submissions focusing on all aspects of chelation treatment (alone or in combination), including nutritional interventions, are welcome. Related and similar topics are also encouraged.
Potential topics include, but are not limited to, the following:
- Chemical characterization of novel metal chelators for chronic and/or acute specific metal intoxication
- Potential metal chelators in human diseases
- Advances in chelation strategies and chelating agents in medicine
- Exploration of the molecular mechanism of metal toxicity and the mechanisms of action for their removal
- Studies devoted to the design and development of chelating agents’ functionalization for sensing or targeting purposes
- Studies on the metal chelators’ properties, i.e., absorption, distribution, metabolism, and excretion
- Potential nutritional intervention for metal detoxification.
Dr. Massimiliano F. Peana
Dr. Christos T. Chasapis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Chelation therapy
- Chelating agents
- Acute and chronic metal intoxication
- Heavy metals
- Toxic metals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.